1. Home
  2. INBS vs NXGL Comparison

INBS vs NXGL Comparison

Compare INBS & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

INBS

Intelligent Bio Solutions Inc.

HOLD

Current Price

$2.31

Market Cap

5.7M

Sector

Health Care

ML Signal

HOLD

Logo NexGel Inc

NXGL

NexGel Inc

SELL

Current Price

$0.61

Market Cap

4.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
INBS
NXGL
Founded
2016
1997
Country
United States
United States
Employees
N/A
19
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7M
4.9M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
INBS
NXGL
Price
$2.31
$0.61
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
71.5K
160.0K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
68.65
N/A
EPS
N/A
N/A
Revenue
$1,980,484.00
N/A
Revenue This Year
$778.48
$50.77
Revenue Next Year
N/A
$46.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.48
52 Week High
$24.90
$2.89

Technical Indicators

Market Signals
Indicator
INBS
NXGL
Relative Strength Index (RSI) 38.81 51.41
Support Level $2.27 $0.57
Resistance Level $3.16 $0.64
Average True Range (ATR) 0.14 0.05
MACD -0.01 0.00
Stochastic Oscillator 12.82 37.37

Price Performance

Historical Comparison
INBS
NXGL

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

About NXGL NexGel Inc

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.

Share on Social Networks: